These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 38802990)
1. ctDNA as a predictor of outcome after curative resection for locally advanced rectal cancer: systematic review and meta-analysis. Nassar A; Aly NE; Jin Z; Aly EH Colorectal Dis; 2024 Jul; 26(7):1346-1358. PubMed ID: 38802990 [TBL] [Abstract][Full Text] [Related]
2. Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer. McDuff SGR; Hardiman KM; Ulintz PJ; Parikh AR; Zheng H; Kim DW; Lennerz JK; Hazar-Rethinam M; Van Seventer EE; Fetter IJ; Nadres B; Eyler CE; Ryan DP; Weekes CD; Clark JW; Cusack JC; Goyal L; Zhu AX; Wo JY; Blaszkowsky LS; Allen J; Corcoran RB; Hong TS JCO Precis Oncol; 2021; 5():. PubMed ID: 34250394 [TBL] [Abstract][Full Text] [Related]
3. Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis. O'Sullivan NJ; Temperley HC; Kyle ET; Sweeney KJ; O'Neill M; Gilham C; O'Sullivan J; O'Kane G; Mehigan B; O'Toole S; Larkin J; Gallagher D; McCormick P; Kelly ME Int J Colorectal Dis; 2024 May; 39(1):82. PubMed ID: 38809315 [TBL] [Abstract][Full Text] [Related]
4. Serial Circulating Tumor DNA in Predicting and Monitoring the Effect of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: A Prospective Multicenter Study. Zhou J; Wang C; Lin G; Xiao Y; Jia W; Xiao G; Liu Q; Wu B; Wu A; Qiu H; Zhang F; Hu K; Xue H; Shen Z; Wang Z; Han J; Niu B; Xu Y; Yu Z; Yang L Clin Cancer Res; 2021 Jan; 27(1):301-310. PubMed ID: 33046514 [TBL] [Abstract][Full Text] [Related]
5. Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study. Tie J; Cohen JD; Wang Y; Li L; Christie M; Simons K; Elsaleh H; Kosmider S; Wong R; Yip D; Lee M; Tran B; Rangiah D; Burge M; Goldstein D; Singh M; Skinner I; Faragher I; Croxford M; Bampton C; Haydon A; Jones IT; S Karapetis C; Price T; Schaefer MJ; Ptak J; Dobbyn L; Silliman N; Kinde I; Tomasetti C; Papadopoulos N; Kinzler K; Volgestein B; Gibbs P Gut; 2019 Apr; 68(4):663-671. PubMed ID: 29420226 [TBL] [Abstract][Full Text] [Related]
6. Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence. Murahashi S; Akiyoshi T; Sano T; Fukunaga Y; Noda T; Ueno M; Zembutsu H Br J Cancer; 2020 Sep; 123(5):803-810. PubMed ID: 32565539 [TBL] [Abstract][Full Text] [Related]
7. MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer. Khakoo S; Carter PD; Brown G; Valeri N; Picchia S; Bali MA; Shaikh R; Jones T; Begum R; Rana I; Wotherspoon A; Terlizzo M; von Loga K; Kalaitzaki E; Saffery C; Watkins D; Tait D; Chau I; Starling N; Hubank M; Cunningham D Clin Cancer Res; 2020 Jan; 26(1):183-192. PubMed ID: 31852830 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of ctDNA Detection in Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis. Chang L; Zhang X; He L; Ma Q; Fang T; Jiang C; Ma Z; Li Q; Wu C; Tao J Oncologist; 2023 Dec; 28(12):e1198-e1208. PubMed ID: 37294663 [TBL] [Abstract][Full Text] [Related]
9. Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial. Vidal J; Casadevall D; Bellosillo B; Pericay C; Garcia-Carbonero R; Losa F; Layos L; Alonso V; Capdevila J; Gallego J; Vera R; Salud A; Martin-Richard M; Nogué M; Cillán E; Maurel J; Faull I; Raymond V; Fernández-Martos C; Montagut C Clin Cancer Res; 2021 May; 27(10):2890-2898. PubMed ID: 33727257 [TBL] [Abstract][Full Text] [Related]
10. The Role of Circulating Tumor DNA for Management of Patients With Rectal Cancer: Challenges and Opportunities. Sahin IH; Yanes R; Saridogan T; Holder-Murray J; Dasari AN Cancer J; 2024 Jul-Aug 01; 30(4):290-296. PubMed ID: 39042781 [TBL] [Abstract][Full Text] [Related]
11. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study. Wang Y; Yang L; Bao H; Fan X; Xia F; Wan J; Shen L; Guan Y; Bao H; Wu X; Xu Y; Shao Y; Sun Y; Tong T; Li X; Xu Y; Cai S; Zhu J; Zhang Z PLoS Med; 2021 Aug; 18(8):e1003741. PubMed ID: 34464382 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Serum NPY Hypermethylation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Secondary Analysis of a Randomized Trial. Appelt AL; Andersen RF; Lindebjerg J; Jakobsen A Am J Clin Oncol; 2020 Jan; 43(1):9-13. PubMed ID: 31569168 [TBL] [Abstract][Full Text] [Related]
13. ctDNA on liquid biopsy for predicting response and prognosis in locally advanced rectal cancer: A systematic review. Morais M; Pinto DM; Machado JC; Carneiro S Eur J Surg Oncol; 2022 Jan; 48(1):218-227. PubMed ID: 34511270 [TBL] [Abstract][Full Text] [Related]
14. Treatment stratification and prognosis assessment using circulating tumor DNA in locally advanced rectal cancer: A systematic review and meta-analysis. Mi J; Wang R; Han X; Ma R; Zhao D Cancer Med; 2023 Sep; 12(17):17934-17944. PubMed ID: 37553845 [TBL] [Abstract][Full Text] [Related]
15. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis. Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112 [TBL] [Abstract][Full Text] [Related]
16. Circulating tumor DNA sequencing for colorectal cancers: A comparative analysis of colon cancer and rectal cancer data. Huang K; Qu H; Zhang X; Huang T; Sun X; He W; Li M; Lin L; Xu M; Chen S; Xia L Cancer Biomark; 2019; 26(3):313-322. PubMed ID: 31561327 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy: A Systematic Review and Network Meta-Analysis. Turri G; Ostuzzi G; Vita G; Barresi V; Scarpa A; Milella M; Mazzarotto R; Ruzzenente A; Barbui C; Pedrazzani C JAMA Netw Open; 2024 Jun; 7(6):e2414702. PubMed ID: 38833249 [TBL] [Abstract][Full Text] [Related]
18. Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA. Benešová L; Hálková T; Ptáčková R; Semyakina A; Menclová K; Pudil J; Ryska M; Levý M; Šimša J; Pazdírek F; Hoch J; Blaha M; Minárik M World J Gastroenterol; 2019 Dec; 25(48):6939-6948. PubMed ID: 31908397 [TBL] [Abstract][Full Text] [Related]
19. Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer. Yang J; Gong Y; Lam VK; Shi Y; Guan Y; Zhang Y; Ji L; Chen Y; Zhao Y; Qian F; Chen J; Li P; Zhang F; Wang J; Zhang X; Yang L; Kopetz S; Futreal PA; Zhang J; Yi X; Xia X; Yu P Cell Death Dis; 2020 May; 11(5):346. PubMed ID: 32393783 [TBL] [Abstract][Full Text] [Related]
20. Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer. Waldeck S; Mitschke J; Wiesemann S; Rassner M; Andrieux G; Deuter M; Mutter J; Lüchtenborg AM; Kottmann D; Titze L; Zeisel C; Jolic M; Philipp U; Lassmann S; Bronsert P; Greil C; Rawluk J; Becker H; Isbell L; Müller A; Doostkam S; Passlick B; Börries M; Duyster J; Wehrle J; Scherer F; von Bubnoff N Mol Oncol; 2022 Jan; 16(2):527-537. PubMed ID: 34653314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]